Bohner Andrew, Qureshi Humza, Mysore Sachin, Kumar Arjun, Koneru Manisha
Neurosciences, Cooper Medical School of Rowan University, Camden, USA.
Neurointerventional Surgery, Cooper University Health Care, Camden, USA.
Cureus. 2025 Apr 29;17(4):e83197. doi: 10.7759/cureus.83197. eCollection 2025 Apr.
Recent advancements in embolic agents and endovascular techniques have led to increased interest in exploring endovascular embolization as a viable treatment for brain arteriovenous malformations. Several trials have investigated the use of various embolic agents for the treatment of arteriovenous malformations (AVMs) endovascularly. However, the reporting outcomes and design elements in these studies are heterogeneous and include inclusion/exclusion criteria and evaluated endpoints. This scoping review synthesized common endpoints cited within embolic endovascular AVM trials for monitoring their safety and efficacy, with a commentary on common threads of focus in future trials for evaluating AVM treatment, including adapting designs to be on par with the pace of advancements in endovascular technologies.
栓塞剂和血管内技术的最新进展引发了人们对探索血管内栓塞作为脑动静脉畸形可行治疗方法的兴趣增加。多项试验研究了使用各种栓塞剂进行血管内治疗动静脉畸形(AVM)。然而,这些研究中的报告结果和设计要素存在异质性,包括纳入/排除标准和评估终点。本范围综述综合了血管内栓塞AVM试验中引用的常见终点,以监测其安全性和有效性,并对未来评估AVM治疗的试验中常见的关注要点进行了评论,包括使设计跟上血管内技术进步的步伐。